Our $100,000, 2-year grant will support pilot research projects focused on investigating strategies that increase accrual in lung cancer clinical trials. Learn more about the Accelerate Clinical Trials Grant.
In 2015, we awarded two $600,000, 3-year research grants focused on preventing or stopping lung cancer metastasis. Research advances in this area will significantly improve survival and allow patients who are diagnosed with lung cancer live longer, better lives. Learn about the Metastasis Grant.
Investment in research has significantly improved survival rates for other cancers in the past several decades. With your support, Free to Breathe is working to make lung cancer a part of this story. That's why research is a critical part of our vision to double lung cancer survival by 2022.
Lung cancer claims more lives each year than breast, colon and prostate cancer combined, but these cancers receive proportionately more research funding than lung cancer.
As research funding grows, survival rates increase. Dramatic increases in survival won't happen until we fund the research necessary for better detection and treatment.
That's why Free to Breathe has awarded more than $5 million for cutting-edge research that is essential to helping patients live longer and better lives.
"Patients and their families look to the scientific community for hope. We have a responsibility to bring them more cures."
Jolene Hulson, our May Hero Spotlight, lost a close friend and her brother to lung cancer. Read about how the Action Summit connected her with other passionate advocates and provided the tools to take her own advocacy further than ever before.More...
The Lung Cancer Action Summit in Pittsburgh has wrapped up. Social Media Ambassador Rachel Troychock shares some final thoughts from the inspiring weekend.More...
@2016 Free To Breathe | All rights reserved. | Federal tax exempt ID number: 45-0505050.